SERA NASDAQ
Salt Lake City, UT 84109
US
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kearney Paul | 0 | — | 2026-03-12 | |
| Harrison Robert Gard | 0 | — | 2026-03-12 | |
| Boniface John J. | 0 | — | 2026-03-12 | |
| Lindgardt Zhenya | A-Award | 154,440 | — | 2026-03-12 |
| Lindgardt Zhenya | A-Award | 239,442 | $1.99 | 2026-03-12 |